 The likelihood of re-identification is a factor in determining the probability that the patient's information has been compromised.Commonly, pharmacies sell de-identified information to data mining companies that sell to pharmaceutical companies in turn.There have been state laws enacted to ban data mining of medical information, but they were struck down by federal courts in Maine and New Hampshire on First Amendment grounds.